270 related articles for article (PubMed ID: 8985284)
21. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
22. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings.
Adams PC; Agnew S
Hepatology; 1996 Apr; 23(4):724-7. PubMed ID: 8666324
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, canada).
Rivard SR; Mura C; Simard H; Simard R; Grimard D; Le Gac G; Raguenes O; Férec C; De Braekeleer M
Blood Cells Mol Dis; 2000 Feb; 26(1):10-4. PubMed ID: 10772871
[TBL] [Abstract][Full Text] [Related]
24. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
[TBL] [Abstract][Full Text] [Related]
25. [Defective iron metabolism in genetic hemochromatosis. The mechanisms remain unknown in spite of genetic advances].
Stål P; Hagen K; Hultcrantz R
Lakartidningen; 1998 Aug; 95(32-33):3430-5. PubMed ID: 9725962
[TBL] [Abstract][Full Text] [Related]
26. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
Adams PC; Kertesz AE; Valberg LS
Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
[TBL] [Abstract][Full Text] [Related]
27. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
[TBL] [Abstract][Full Text] [Related]
28. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families.
Adams PC; Campion ML; Gandon G; LeGall JY; David V; Jouanolle AM
Hepatology; 1997 Oct; 26(4):986-90. PubMed ID: 9328324
[TBL] [Abstract][Full Text] [Related]
29. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.
Cruz E; Melo G; Lacerda R; Almeida S; Porto G
Blood Cells Mol Dis; 2006; 37(1):33-9. PubMed ID: 16762569
[TBL] [Abstract][Full Text] [Related]
30. Hereditary hemochromatosis.
Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
[TBL] [Abstract][Full Text] [Related]
31. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.
Deugnier YM; Charalambous P; Le Quilleuc D; Turlin B; Searle J; Brissot P; Powell LW; Halliday JW
Hepatology; 1993 Dec; 18(6):1363-9. PubMed ID: 7902316
[TBL] [Abstract][Full Text] [Related]
32. Hepatic and serum ferritin concentrations in patients with idiopathic hemochromatosis.
Beaumont C; Simon M; Smith PM; Worwood M
Gastroenterology; 1980 Nov; 79(5 Pt 1):877-83. PubMed ID: 7419012
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of genetic hemochromatosis].
Moirand R; Guillygomarc'h A; Brissot P; Deugnier Y
Rev Prat; 2000 May; 50(9):977-82. PubMed ID: 10865497
[TBL] [Abstract][Full Text] [Related]
34. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
35. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.
Nielsen P; Günther U; Dürken M; Fischer R; Düllmann J
J Lab Clin Med; 2000 May; 135(5):413-8. PubMed ID: 10811057
[TBL] [Abstract][Full Text] [Related]
36. Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis.
Pawlotsky Y; Le Dantec P; Moirand R; Guggenbuhl P; Jouanolle AM; Catheline M; Meadeb J; Brissot P; Deugnier Y; Chalès G
Arthritis Rheum; 1999 Apr; 42(4):799-806. PubMed ID: 10211896
[TBL] [Abstract][Full Text] [Related]
37. Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies.
Silver MM; Beverley DW; Valberg LS; Cutz E; Phillips MJ; Shaheed WA
Am J Pathol; 1987 Sep; 128(3):538-54. PubMed ID: 3307444
[TBL] [Abstract][Full Text] [Related]
38. [Secondary hepatic hemochromatosis: diagnosis and quantification with 0.5 T magnetic resonance. Value and limitations].
Tamburrini O; Andò S; Della Sala M; Maggiolini M; Sessa M
Radiol Med; 1993 Dec; 86(6):841-6. PubMed ID: 8296005
[TBL] [Abstract][Full Text] [Related]
39. Iron-responsive element-binding protein in hemochromatosis liver and intestine.
Flanagan PR; Hajdu A; Adams PC
Hepatology; 1995 Sep; 22(3):828-32. PubMed ID: 7657289
[TBL] [Abstract][Full Text] [Related]
40. Clinical features of genetic hemochromatosis in women compared with men.
Moirand R; Adams PC; Bicheler V; Brissot P; Deugnier Y
Ann Intern Med; 1997 Jul; 127(2):105-10. PubMed ID: 9229998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
